We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for Masimo (MASI) Q3 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
In its upcoming report, Masimo (MASI - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.84 per share, reflecting an increase of 33.3% compared to the same period last year. Revenues are forecasted to be $502.58 million, representing a year-over-year increase of 4.9%.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific Masimo metrics that are commonly monitored and projected by Wall Street analysts.
It is projected by analysts that the 'Revenue- Non-healthcare' will reach $164.74 million. The estimate indicates a year-over-year change of -3.7%.
The collective assessment of analysts points to an estimated 'Revenue- Healthcare' of $338.84 million. The estimate indicates a year-over-year change of +10.1%.
Analysts expect 'Gross Profit- Non-healthcare' to come in at $56.76 million. The estimate compares to the year-ago value of $55.80 million.
The consensus estimate for 'Gross Profit- Healthcare' stands at $210.17 million. Compared to the present estimate, the company reported $185.60 million in the same quarter last year.
Shares of Masimo have demonstrated returns of +3.9% over the past month compared to the Zacks S&P 500 composite's +0.4% change. With a Zacks Rank #2 (Buy), MASI is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Exploring Analyst Estimates for Masimo (MASI) Q3 Earnings, Beyond Revenue and EPS
In its upcoming report, Masimo (MASI - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.84 per share, reflecting an increase of 33.3% compared to the same period last year. Revenues are forecasted to be $502.58 million, representing a year-over-year increase of 4.9%.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific Masimo metrics that are commonly monitored and projected by Wall Street analysts.
It is projected by analysts that the 'Revenue- Non-healthcare' will reach $164.74 million. The estimate indicates a year-over-year change of -3.7%.
The collective assessment of analysts points to an estimated 'Revenue- Healthcare' of $338.84 million. The estimate indicates a year-over-year change of +10.1%.
Analysts expect 'Gross Profit- Non-healthcare' to come in at $56.76 million. The estimate compares to the year-ago value of $55.80 million.
The consensus estimate for 'Gross Profit- Healthcare' stands at $210.17 million. Compared to the present estimate, the company reported $185.60 million in the same quarter last year.
View all Key Company Metrics for Masimo here>>>
Shares of Masimo have demonstrated returns of +3.9% over the past month compared to the Zacks S&P 500 composite's +0.4% change. With a Zacks Rank #2 (Buy), MASI is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>